-0.52%
Today
Loading 1D prices…
Company profile
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
MALVERN, PA, United States
Employees
658
Fiscal year end
1231
CIK
1227636
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PROFProfound Medical Corp. Common Stock | $213M | $16.1M | -264.44% | $1.41 | -2.24% | Buy |
| PDEXPro-Dex Inc. Common Stock | $230.2M | $77.5M | +17.62% | $4.12 | +7.38% | Hold |
| UTMDUtah Medical Products Inc. Common Stock | $235.8M | $38.5M | +29.30% | $3.48 | -0.76% | Unrated |
| OSUROraSure Technologies Inc. Common Stock | $240M | $115M | -59.76% | -$0.94 | +0.58% | Hold |
| INFUInfuSystems Holdings Inc. Common Stock | $248M | $143.4M | +4.62% | $0.31 | +1.55% | Buy |